Dr. Baptista prescribes a range of GLP-1 receptor agonist medications as part of a physician-supervised medical weight loss program. These medications are prescribed only after an individual evaluation of your health history, goals, and insurance coverage.
No single medication is right for everyone, and this page does not recommend one medication over another. It is intended as patient education. The right option for you, if any, is determined together with Dr. Baptista during your consultation.
Medications Approved for Weight Management
Wegovy (semaglutide)
A once-weekly injection, FDA-approved for chronic weight management and for reducing cardiovascular risk in adults with obesity and heart disease.
Saxenda (liraglutide)
A once-daily injection, FDA-approved for chronic weight management.
Zepbound (tirzepatide)
A once-weekly injection, FDA-approved for chronic weight management and for obstructive sleep apnea in adults with obesity.
Related GLP-1 Medications
These medications are FDA-approved for type 2 diabetes. Patients often ask about them by name. Whether any of them fits a weight-management plan is a clinical decision made during consultation.
Ozempic (semaglutide)
A once-weekly injection approved for type 2 diabetes, cardiovascular risk reduction, and chronic kidney disease.
Rybelsus (semaglutide)
A once-daily tablet approved for type 2 diabetes.
Victoza (liraglutide)
A once-daily injection approved for type 2 diabetes and cardiovascular risk reduction.
Trulicity (dulaglutide)
A once-weekly injection approved for type 2 diabetes and cardiovascular risk reduction.
Mounjaro (tirzepatide)
A once-weekly injection approved for type 2 diabetes.
Earlier GLP-1 Medications
These earlier medications in the GLP-1 class are less commonly used today but are included for completeness.
Byetta (exenatide)
A twice-daily injection approved for type 2 diabetes.
Bydureon (exenatide extended-release)
A once-weekly injection approved for type 2 diabetes; availability varies.
Adlyxin (lixisenatide)
A once-daily injection approved for type 2 diabetes, available in the US mainly in combination as Soliqua.
Tanzeum (albiglutide)
A once-weekly injection approved for type 2 diabetes; withdrawn in many regions.